Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Genetic markers for predicting responsiveness to therapy with HDL-raising or HDL mimicking agent

Genetic markers for predicting responsiveness to therapy with HDL-raising or HDL mimicking agent

US Patent 10584385 · Granted Mar 10, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Genetic markers for predicting responsiveness to therapy with HDL-raising or HDL2025
Genetic markers for predicting responsiveness to therapy with HDL-raising or HDL2025
Cabinet pill dispenser2025
Methods of treating acute respiratory distress syndrome using colchicine2023
Co-culture system and method for in vitro assessment of reverse cholesterol tran2023
CETP inhibitors for therapeutic use2023
CETP inhibitors for therapeutic use2023
Early administration of low-dose colchicine after myocardial infarction2022
Genetic markers for predicting responsiveness to therapy with HDL-raising or HDL2022
Genetic markers for predicting responsiveness to therapy with HDL-raising or HDL2022
CETP inhibitors for therapeutic use2020
CETP inhibitors for therapeutic use2020